NOX4 and gestational diabetes: IPA of our RNA sequencing dataset generated from CB-ECFCs isolated from healthy donors and those with gestational diabetes (Fig. 4) indicated that NOX4 downregulation in diabetic CB-ECFCs may directly inhibit SERPINE1 expression with consequent reduction in angiogenic capacity (Fig. 6A).